Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2005, Vol. 10 ›› Issue (6): 674-676.

Previous Articles     Next Articles

In vivo study on apoptosis and cell proliferation induced by adriamycin in mice with MCF-7 breast cancer

WANG Wen-wu, OU-YANG Xue-nong, JIANG Hao1   

  1. Department of Oncology, NanJing Military Command Fuzhou General Hospital, Fuzhou 350025, Fujian, China; 1Department of Oncology, the First Hospital Affiliated to Nanhua Uniuersity, Hengyang 421000, Hunan, China
  • Received:2005-02-28 Revised:2005-04-06 Online:2005-06-26 Published:2020-11-12

Abstract: AIM: To observe the apoptosis and cell proliferation induced by adriamycin in mice with breast cancer. METHODS: Therapeutic effect of 1.25 mg·kg-1 adriamycin (ADR)on mice MCF-7 breast cancer was observed in vivo. Apoptosis and PCNA of tumor cells were also studied by TUNEL and immune his to chemical methods. RESULTS: In the control group, the apoptotic cell index (AI)in tumor cell was 1.11 %and PCNA index (PI)was 56.38 %.In the ADR group, the rate of tumor inhibition was 43 % and the AI was 1.93 % (P <0.05).The 35.75 % of PI in ADR group was lower than that in the control group (P <0.01). CONCLUSION: Adriamycin may induce apoptosis and reduce cell proliferation.

Key words: adriamycin, breast neoplasm, apoptosis, PCNA

CLC Number: